PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$0.94
-0.02 (-2.14%)
Open$0.99
Previous Close$0.96
Day High$0.99
Day Low$0.90
52W High$7.95
52W Low$0.85
Volume—
Avg Volume744.6K
Market Cap3.10M
P/E Ratio—
EPS$-12.92
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,171.0% upside
Current
$0.94
$0.94
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 79.7K | 3.33M | 3.45M |
| Net Income | -22,711,522 | 722.6K | 805.0K |
| Profit Margin | -28,458.8% | 21.7% | 23.3% |
| EBITDA | -20,481,556 | 1.33M | 1.25M |
| Free Cash Flow | — | 449.2K | 396.5K |
| Rev Growth | — | -7.5% | +9.4% |
| Debt/Equity | — | 0.57 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |